Abstract:Sustained stress leads to series of changes in the brain, firstly through the activation of hypothalamus–pituitary–adrenal (HPA) axis and sympathetic nervous system (SNS) axis, then the release of glucocorticoid (GCs) and catecholamines (CAs), respectively. The circulating GCs can cause neuronal injury and even the loss of neurons, accompanying the increased level of proinflammatory cytokines in the circulation. Chronic stress has been linked to various diseases, especially mood disorders and neuropsychiatric disorders, mainly mediated by the limbic system. Yet the relationship between chronic stress and neurodegenerative disorders such as Alzheimer disease (AD) and Parkinson’s disease (PD) is unknown. It has been found that depression often precedes PD symptoms in clinical subjects [1], while many PD patients present with depression symptoms as well [2,3]. A recent study published in Molecular Psychiatry by Hemmerle et al. [4] addressed this point by subjecting 6-OHDA-lesioned rats to the chronic stress, and they found that chronic stress exacerbates the loss of dopamine neurons induced by 6-OHDA injection. The results strongly argued that chronic stress may function as an important factor in the development of PD and potentially other neurodegenerative diseases. Hemmerle et al. generated a rat model of PD by unilateral 6-OHDA injection, which produces selective toxicity to dopamine neurons, especially in substantia nigra. The dopamine neuron loss leads to motor behavior deficits, as reflected by the forelimb asymmetry test, because the loss of dopamine neurons would lead to impaired usage of the contralateral limb, while the severity of dopamine neuron loss was histologically examined by TH staining [4]. When the rats were subjected to chronic unpredictable stress, the authors found that the rats would demonstrate increased forelimb asymmetry (suggestive of worse behavior), which correlated with increased dopamine neuron loss (decreased TH staining). Interestingly, the chronic stress alone did not induce loss of dopamine neurons, and the stress had to occur simultaneously with toxin exposure [4], suggesting that the stress might act adjuvantly with the toxin or increase the vulnerability of the neurons. In clinical studies, depression as the most common disease caused by chronic stress may occur prior to PD symptoms [1] and may indicate worse prognosis for PD patients [5]. Yet it should be noted that the loss of dopamine neurons could occur much earlier to the motor symptoms [6] and therefore may be concurrent with the depression as well. What are the potential mechanisms linking stress and increased dopamine neuron loss? It is possible that glucocorticoid contributes to this process, partly through the glucocorticoid receptors (GRs) on the microglia, because MPTP-induced neurotoxicity was less in mice whose GRs were knocked down selectively on microglial cells [7]. In addition, GRs on dopamine neurons regulate the activity of the cells and might sensitize the neurons through excitotoxicity [8]. On the other hand, there is evidence suggesting that the depression can be caused by loss of dopaminergic innervation during PD progression [2], acting as the downstream of PD pathology. It is believed that the mesolimbic and mesocortical dopaminergic pathways that are disrupted in PD would contribute to the depression symptoms [3]. Indeed, a recent study has shown that selective activation of midbrain dopamine neurons with optogenetic tech-

Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology

Chronic Corticosterone Administration-Induced Mood Disorders in Laboratory Rodents: Features, Mechanisms, and Research Perspectives

Chronic Corticosterone Exposure Impairs Emotional Regulation and Cognitive Function Through Disturbing Neural Oscillations in Mice.

Impaired Functional Connectivity of Cortico-Amygdala Pathway Can Drive Social Behavior Deficits in Synucleinopathies

Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy

α-Synuclein aggregation decreases cortico-amygdala connectivity and impairs social behavior in mice

Lifelong Chronic Psychosocial Stress Induces a Proteomic Signature of Alzheimer's Disease in Wildtype Mice.

Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice

Chronic psychosocial stress in mice leads to changes in brain functional connectivity and metabolite levels comparable to human depression

Neurodegeneration in the centrally-projecting Edinger–Westphal nucleus contributes to the non-motor symptoms of Parkinson’s disease in the rat

Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

Chronic corticosterone exposure causes anxiety- and depression-related behaviors with altered gut microbial and brain metabolomic profiles in adult male C57BL/6J mice

Chronic Stress and Parkinson's Disease

Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease

Circadian Disruption Promotes the Neurotoxicity of Oligomeric Alpha-Synuclein in Mice

Aberrant Adenosine A(2a) Receptor Signaling Contributes To Neurodegeneration And Cognitive Impairments In A Mouse Model Of Synucleinopathy

Hypothalamic Proteomic Analysis Reveals Dysregulation of Glutamate Balance and Energy Metabolism in a Mouse Model of Chronic Mild Stress-Induced Depression

Cyclical administration of corticosterone results in aggravation of depression-like behaviors and accompanying downregulations in reelin in an animal model of chronic stress relevant to human recurrent depression

Hyperactive neuronal autophagy depletes BDNF and impairs adult hippocampal neurogenesis in a corticosterone-induced mouse model of depression

Chronic psychosocial stress triggers microglial-/macrophage-induced inflammatory responses leading to neuronal dysfunction and depressive-related behavior